晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02228 晶泰控股

未开盘 08-11 16:08:13

8.325

+0.195

+2.40%

最高8.605	最低8.175	成交量9,366万
今开8.260	昨收8.130	日振幅5.29%
总市值358.22亿	流通市值358.22亿	总股本43.03亿
成交额7.89亿	换手率2.18%	流通股本43.03亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股","latestPrice":8.325,"timestamp":1786435693004,"preClose":8.13,"halted":0,"volume":93664649,"delay":0,"changeRate":0.023985239852398338,"floatShares":4303000000,"shares":4303000000,"eps":0.03489402939399409,"marketStatus":"未开盘","change":0.195,"latestTime":"08-11 16:08:13","open":8.26,"high":8.605,"low":8.175,"amount":789247031,"amplitude":0.052891,"askPrice":8.325,"askSize":130000,"bidPrice":8.315,"bidSize":31000,"shortable":3,"etf":0,"ttmEps":0.03489402939399409,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786498200000},"marketStatusCode":0,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":8.13,"openAndCloseTimeList":[[1786411800000,1786420800000],[1786424400000,1786435200000]],"volumeRatio":1.3145957679290137,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02228","defaultTab":"news","newsList":[{"id":"2658369969","title":"创新药概念继续走强 金斯瑞生物科技（01548）涨6.87% 机构指中国创新药全球地位持续提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2658369969","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658369969?lang=zh_cn&edition=full","pubTime":"2026-08-11 11:15","pubTimestamp":1786418137,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股创新药概念持续走强，截至发稿，金斯瑞生物科技 涨6.87%，再鼎医药涨5.51%，同源康医药-B涨4.81%，晶泰控股涨3.94%，药明合联涨3.92%，翰森制药涨3.76%，亚盛医药涨3.63%，百济神州涨3.38%，药明康德涨3.03%，诺诚健华涨2.83%，石药集团涨2.78%。国元国际证券亦表示，出海交易量价齐升，中国创新药全球地位持续提升。中国创新药出海持续超预期，上半年997亿美元的交易总额和全球TOP10中独占8席的成绩，充分验证了中国创新药资产的全球竞争力。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987912","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","LU1951186391.HKD","LU0315179316.USD","06978","BK1515","LU0072913022.USD","BK1161","LNGR","IE00B031HY20.USD","HK0000306685.HKD","IE00B5MMRT66.SGD","LU1226287875.USD","BK1617","LU2328871848.SGD","01548","06160","01093","BK1588","03692","159992","HK0000320223.HKD","IE00B543WZ88.USD","LU2125910500.SGD","02359","06855","KURE","LU2039709279.SGD","LU1152091168.USD","BK1576","BK1521","09969","09688","IE00BZ08YS42.EUR","LU1226288170.HKD","IBBQ","LU0326950275.SGD","LU1226287792.SGD","LU1303224171.USD","LU1993786604.SGD","LU2242644610.SGD","MEDX","LU1813983027.USD","02228","IE00BZ08YR35.GBP","BK1583","02410","02268","IE00BZ08YT58.USD","LU2488822045.USD","LU0880133367.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198305012","title":"异动解读 | 晶泰控股盘中大涨5.04%，AI平台发布及大行唱好持续催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1198305012","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198305012?lang=zh_cn&edition=full","pubTime":"2026-08-11 09:38","pubTimestamp":1786412305,"startTime":"0","endTime":"0","summary":"晶泰控股（02228）今日盘中股价大幅拉升，一度涨超5%，延续近期的强势表现，引发市场广泛关注。消息面上，公司近日正式发布XtalPi Science科学智能平台，并联合26家机构发起“科学智能开放生态联盟”，市场对其估值逻辑由CRO服务商向AI平台型公司切换的预期持续升温。同时，摩根大通首次给予公司“增持”评级，浙商证券维持“买入”评级，并指出剔除一次性管线影响后主业同比增长65%，机构看多共识进一步巩固。此外，公司将于近期召开董事会审议中期业绩，业绩窗口期临近亦吸引资金关注。板块层面，生命科学工具和服务行业今日整体走强，AI制药赛道资金共振对公司股价形成正向带动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197408322","title":"异动解读｜晶泰控股盘中上涨5.6%，AI平台发布及大行唱好延续催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1197408322","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197408322?lang=zh_cn&edition=full","pubTime":"2026-08-11 09:36","pubTimestamp":1786412206,"startTime":"0","endTime":"0","summary":"8月11日，晶泰控股盘中上涨5.6%，报8.585港元，成交额1.16亿港元，延续前一交易日强势表现。消息面上，公司近日正式发布XtalPi Science科学智能平台，并联合26家机构发起\"科学智能开放生态联盟\"，市场对其估值逻辑由CRO服务商向AI平台型公司切换的预期持续升温。板块层面，生命科学工具和服务行业今日整体走强，康龙化成涨3.06%、药明康德涨2.22%、金斯瑞生物科技涨1.74%，AI制药赛道资金共振对公司股价形成正向带动。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658097936","title":"AI医疗概念股普升 剂泰科技-P（07666）涨12.86%、晶泰控股（02228）涨10.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658097936","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658097936?lang=zh_cn&edition=full","pubTime":"2026-08-10 10:03","pubTimestamp":1786327392,"startTime":"0","endTime":"0","summary":"金吾财讯 | AI医疗概念股盘初普升，截至发稿，剂泰科技-P 涨12.86%，晶泰控股涨10.26%，英硅智能涨9.38%，百奥赛图-B涨8.33%，讯飞医疗科技涨4.98%，医渡科技涨4.00%，云知声涨3.96%，平安好医生涨3.58%，阿里健康涨3.21%，京东健康涨2.98%。AIDD有望重塑早期药物发现的流程，大大加速早期药物筛选的效率及成功率，相关干实验投入的增加以及对湿实验需求持续的增长，有望为下游产业链持续带来增量。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/NDQ1MWJhN2NhODAzMzgwYTAyY2UxMDMzODA5NjE3NDc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NDQ1MWJhN2NhODAzMzgwYTAyY2UxMDMzODA5NjE3NDc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987779","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01833","BK1109","BK1141","BK1189","BK1219","LU0051755006.USD","BK1142","86618","SGXZ62798434.SGD","BK1615","SGXZ86797644.SGD","02315","02506","HK0000165453.HKD","02228","BK1584","ARTY","BK1501","00241","LU0456827905.SGD","AIPO","BK1589","07666","BK1515","BK1247","BK1161","VTHR","AGIX","06618","BK1502","03696","BK1571","BK1591","159891","QTOC","BK1518","02158","BK1583","BK1610","CHAT","09678","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121716613","title":"异动解读 | 晶泰控股盘中大涨9.87%，AI平台发布叠加板块共振及大行唱好","url":"https://stock-news.laohu8.com/highlight/detail?id=1121716613","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121716613?lang=zh_cn&edition=full","pubTime":"2026-08-10 09:54","pubTimestamp":1786326871,"startTime":"0","endTime":"0","summary":"晶泰控股(02228)今日盘中股价大涨9.87%，引发市场广泛关注。消息面上，公司近日正式发布XtalPi Science科学智能平台，并联合26家机构发起“科学智能开放生态联盟”，市场对其估值逻辑由CRO服务商向AI平台型公司切换的预期显著升温。同时，摩根大通近期首予公司“增持”评级，浙商证券维持“买入”评级并指出剔除一次性管线影响后主业同比增长65%，进一步提振了投资者信心。此外，公司即将召开董事会审议中期业绩，业绩窗口期临近亦吸引了资金关注。板块层面，生命科学工具和服务行业今日整体走强，AI制药赛道资金共振明显，对晶泰控股的股价也形成了正向带动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183371391","title":"异动解读｜晶泰控股盘中上涨7.28%，AI制药板块集体走强叠加平台发布催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1183371391","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183371391?lang=zh_cn&edition=full","pubTime":"2026-08-10 09:31","pubTimestamp":1786325469,"startTime":"0","endTime":"0","summary":"8月10日，晶泰控股盘中上涨7.28%，报8.11港元，成交额3678.24万港元。消息面上，公司近日正式发布XtalPi Science科学智能平台，并联合26家机构发起\"科学智能开放生态联盟\"，市场对其估值逻辑由CRO服务商向AI平台型公司切换的预期升温。此外，公司8月19日将召开董事会审议中期业绩，业绩窗口期临近亦提振资金关注。板块层面，生命科学工具和服务行业今日整体走强，英矽智能涨9.6%、金斯瑞生物科技涨7.4%、药明生物涨5.02%，AI制药赛道资金共振明显。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128332112","title":"晶泰控股（02228）拟于2026年8月19日召开董事会审议中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1128332112","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128332112?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:41","pubTimestamp":1786092065,"startTime":"0","endTime":"0","summary":"晶泰控股有限公司（02228）8月7日公告称，公司董事会将于2026年8月19日（星期三）召开会议，主要议程包括：1）审议并批准集团截至2026年6月30日止六个月的中期业绩及其发布；2）研究派发股息（如有）；3）处理其他事项。\n公告同时披露，董事会现由七名成员组成，包括执行董事温书豪博士、马健博士、赖力鹏博士及蒋一得博士；以及独立非执行董事罗卓坚先生、陈颖琪女士和周明笙先生。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657694905","title":"AI Coding之后，大模型下一个重点比拼的是什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2657694905","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657694905?lang=zh_cn&edition=full","pubTime":"2026-08-07 14:15","pubTimestamp":1786083316,"startTime":"0","endTime":"0","summary":"过去十八个月，AI编程领域经历了一场堪称狂飙的进化。代码生成、测试、优化的飞轮越转越快，据AI投研平台Funda测算，未来12个月，OpenAI与Anthropic合计年化收入有望达到约1200亿美元，AI Coding正是其中重要的增长引擎。上海AI实验室联合100位科学家自建的科研流程测评中，最前沿的大模型得分不超过50分。Anthropic发布了科研智能体工作台Claude Science，字节跳动启动了Seed STEM科学家计划。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026080700020336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02228","BK1141","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103693879","title":"晶泰控股更新2026年7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1103693879","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103693879?lang=zh_cn&edition=full","pubTime":"2026-08-06 22:31","pubTimestamp":1786026674,"startTime":"0","endTime":"0","summary":"晶泰控股有限公司于2026年8月6日发布截至2026年7月31日的股份变动月报表。根据公告内容，公司注册股本在报告期内保持不变，截至7月底，法定/注册股本总额为USD 1,000,000，已发行股份数量为4,303,469,679股，库存股份为0股，较上月无变化。报告期内，公司未发生股份新增发行、购回或注销活动，股本维持稳定。据公告披露，2026年5月20日采纳的2026年股份计划新增授出34,980,210份期权，本月底结存34,980,210份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657508774","title":"十年积累，全球唯一：晶泰XtalPi Science平台发布背后的估值逻辑切换","url":"https://stock-news.laohu8.com/highlight/detail?id=2657508774","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657508774?lang=zh_cn&edition=full","pubTime":"2026-08-06 09:46","pubTimestamp":1785980766,"startTime":"0","endTime":"0","summary":"晶泰科技正式发布XtalPi Science科学智能平台，并联合26家机构发起“科学智能开放生态联盟”。","market":"hk","thumbnail":"https://img7.gelonghui.com/column/8.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/8.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/5924513","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK6511","VGT","BK4588","QTOC","VTHR","AGIX","BK1617","02228","BK1141","5RE.SI","AIPO","BK4585","BK6092","ARTY","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134550779","title":"异动解读｜晶泰控股盘中上涨5.2%，券商维持买入评级叠加医药板块回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=1134550779","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134550779?lang=zh_cn&edition=full","pubTime":"2026-08-05 13:25","pubTimestamp":1785907552,"startTime":"0","endTime":"0","summary":"8月5日，晶泰控股盘中上涨5.2%，报7.385港元，成交额2.12亿港元。消息面上，浙商证券8月3日发布研报维持晶泰控股\"买入\"评级，指出剔除去年同期DoveTree一次性管线BD收入高基数影响后，公司主业收入达2.5亿元人民币，同比增长65%，其中AI for Science智慧解决方案业务收入超1.8亿元，同比增幅高达120%。此外，8月4日港股医疗板块整体走强，药明康德涨超12%，金斯瑞生物科技涨超10%，板块联动效应延续至今日，对晶泰控股形成支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"晶泰控股盘中上涨5.2%，券商维持买入评级叠加医药板块回暖","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656632468","title":"【券商聚焦】浙商证券维持晶泰控股（02228）买入评级 指主业强劲增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2656632468","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656632468?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:44","pubTimestamp":1785746692,"startTime":"0","endTime":"0","summary":"金吾财讯 | 浙商证券发布研报指，晶泰控股 发布2026年上半年业绩预告，表观收入同比下滑22.6%-26.5%至3.8–4.0亿元人民币，归母净亏损2.15–2.75亿元，由盈转亏。剔除该单一管线影响后，公司主业维持强劲增长，整体收入达2.5亿元人民币，同比增长65%。浙商证券认为，AI4S赛道仍处高速发展期，早期的大规模投入有助于公司构建小分子、大分子等技术平台及自动化实验室，抢占技术领先优势与行业壁垒。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/ZGNkM2E3NDVjMTk0N2Q5ZDk4NjYxNjc1YjA4NjMzOTA5MjkwMDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZGNkM2E3NDVjMTk0N2Q5ZDk4NjYxNjc1YjA4NjMzOTA5MjkwMDE=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987387","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCE","601878","02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191778479","title":"异动解读｜晶泰控股盘中上涨5.12%，摩根大通首次覆盖给予增持评级叠加板块回暖提振反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1191778479","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191778479?lang=zh_cn&edition=full","pubTime":"2026-07-31 10:51","pubTimestamp":1785466318,"startTime":"0","endTime":"0","summary":"7月31日，晶泰控股盘中上涨5.12%，报6.77港元，成交额1.53亿港元。此前公司因盈利预警连续多日走弱，今日迎来反弹。消息面上，摩根大通近日首次覆盖晶泰控股，给予\"增持\"评级，目标价10港元，较当前股价有约48%上行空间。该行看好晶泰科技以AIDD服务和机器人湿实验室为核心的多元化业务，认为中国AI新药研发行业正由商业探索阶段迈向早期商业化，预计将迎来估值重评。同日生命科学板块整体走强，英矽智能涨7.47%、金斯瑞生物科技涨3.95%，板块情绪回暖亦对个股反弹形成支撑。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"晶泰控股盘中上涨5.12%，摩根大通首次覆盖给予增持评级叠加板块回暖提振反弹","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655870388","title":"晶泰控股发布XtalPi Science平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2655870388","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655870388?lang=zh_cn&edition=full","pubTime":"2026-07-30 20:33","pubTimestamp":1785414801,"startTime":"0","endTime":"0","summary":"7月29日，晶泰控股（2228.HK）发布XtalPiScience科学智能平台与GeniusAgents科学智能体矩阵，同时联合26家产业、高校及科研机构，发起成立“科学智能开放生态联盟”。据介绍，联盟将依托XtalPiScience，为成员提供平台与自动化实验资源的调用、模型与工具接入、联合开发及私有化部署等多元合作模式，共同推动模型、数据、工具与实验能力之间高效协同。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607303826958851.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607303826958851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","BK1617","02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177834504","title":"晶泰控股发布澄清公告：独立董事周明笙不受力高纪律行动影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1177834504","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177834504?lang=zh_cn&edition=full","pubTime":"2026-07-30 18:26","pubTimestamp":1785407161,"startTime":"0","endTime":"0","summary":"晶泰控股有限公司于2026年7月30日公告称，公司董事会已关注到香港联合交易所有限公司在2026年7月28日就力高健康生活有限公司及其两名现任董事发出的纪律行动声明。公告明确指出，相关纪律措施仅适用于力高及声明列明的两名董事，不涉及包括晶泰控股独立非执行董事周明笙在内的其他任何过往或现任董事。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164704413","title":"异动解读｜晶泰控股盘中下跌5.15%，盈利预警引发连续抛压延续走弱","url":"https://stock-news.laohu8.com/highlight/detail?id=1164704413","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164704413?lang=zh_cn&edition=full","pubTime":"2026-07-30 13:03","pubTimestamp":1785387793,"startTime":"0","endTime":"0","summary":"7月30日，晶泰控股盘中下跌5.15%，报6.44港元，成交额2.58亿港元。消息面上，公司于7月24日发布盈利预警，预计上半年归母净亏损约2.15亿至2.75亿元人民币，去年同期为净利润8280万元，由盈转亏。期内收入预计3.8亿至4亿元，同比下降，主要因去年同期确认DoveTree项目5100万美元大额首付款形成高基数。此外，研发费用预计不低于3.4亿元，同比增长超50%，进一步压缩利润空间。盈警发布后股价已连续多日走弱，市场抛压持续。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"晶泰控股盘中下跌5.15%，盈利预警引发连续抛压延续走弱","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655813204","title":"晶泰科技：人工智能驱动科学研究的“先行者”","url":"https://stock-news.laohu8.com/highlight/detail?id=2655813204","media":"经济参考报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655813204?lang=zh_cn&edition=full","pubTime":"2026-07-30 03:26","pubTimestamp":1785353194,"startTime":"0","endTime":"0","summary":"如果说前十年的AI是在虚拟空间中实现逻辑的自动化，那么未来的AI则必须跨入“攻克科学”的深水区。随着AIforScience（即“科学智能”，简称“AI4S”）热度不断攀升，国内外涌现出不少快速成长的企业，晶泰科技就是其中之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607303825516612.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607303825516612.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["QDEC","QQQX","SQQQ","QMAR","QQQ","QQA","LCLG","AIBU","QLD","03455","TARK","PBOT","TQQY","QSWN","161631","AQGX","09086","PSQ","07522","NEWZ","02228","KOMP","ARTY","WPAI","GPIQ","CHAT","NJUL","NOCT","OGIG","FWD","MFIG","MVPS","QQQM","NAPR","AGIX","NJAN","DQJN","QTOC","VUSE","QID","CWC","GK","CPNQ","AIFD","TECY","07568","AIQU","NBDS","TQQQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144294592","title":"异动解读｜晶泰控股盘中下跌5.06%，上半年由盈转亏叠加收入下滑持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1144294592","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144294592?lang=zh_cn&edition=full","pubTime":"2026-07-29 11:17","pubTimestamp":1785295033,"startTime":"0","endTime":"0","summary":"7月29日，晶泰控股盘中下跌5.06%，报6.76港元，成交额2.18亿港元。消息面上，公司于7月24日发布盈利警告，预计上半年归母净亏损约2.15亿至2.75亿元人民币，去年同期为净利润8280万元，由盈转亏。此外，研发费用预计不低于3.4亿元，同比增长超50%，主要源于自主实验室、智能体系统及在研管线相关投入持续加大，进一步压缩利润空间。盈警发布后股价已连续多日走弱，市场抛压延续。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"晶泰控股盘中下跌5.06%，上半年由盈转亏叠加收入下滑持续承压","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654309686","title":"大行评级丨小摩：对中国人工智能新药研发持乐观看法，首予英硅智能及晶泰控股“增持”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2654309686","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654309686?lang=zh_cn&edition=full","pubTime":"2026-07-27 10:54","pubTimestamp":1785120857,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["02228","BK1617","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654968090","title":"晶泰控股(02228)跌2.5% 预期中期由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2654968090","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654968090?lang=zh_cn&edition=full","pubTime":"2026-07-27 10:50","pubTimestamp":1785120601,"startTime":"0","endTime":"0","summary":"金吾财讯 | 晶泰控股(02228)股价受压下行，暂报7.02港元，跌2.5%，成交额2.34亿港元。消息面上，公司发盈警，预期截至2026年6月30日止六个月将录得归属于公司权益持有人的净亏损约2.15亿至2.75亿元（人民币，下同）；去年同期录得净利润约8280万元。公告提到，业绩变动主要由于期内将录得收入约3.8亿元至4亿万元，去年同期录得收入为5.171亿元；期内研发费用不低于3.4亿元，同比增长超过50%，主要由于集团持续加大自主实验室及智能体系统，以及在研管线及多模态技术平台相关投入。","market":"us","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986800","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","02228","BK1617"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://www.xtalpi.com","stockEarnings":[{"period":"1week","weight":0.1859},{"period":"1month","weight":0.0511},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.254},{"period":"1year","weight":0.1174},{"period":"ytd","weight":-0.12}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":0.0611},{"period":"3month","weight":-0.0279},{"period":"6month","weight":-0.051},{"period":"1year","weight":0.03},{"period":"ytd","weight":0.0009}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。该公司主要经营两个业务。药物发现解决方案业务从事就新型药物发现工作为各类生物技术与制药公司和学术机构提供模块独立解决方案或与之合作。智能自动化解决方案业务从事提供固态研发服务及自动化化学合成服务。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.06643},{"month":2,"riseRate":0.285714,"avgChangeRate":0.016028},{"month":3,"riseRate":0,"avgChangeRate":-0.069153},{"month":4,"riseRate":0.666667,"avgChangeRate":0.048494},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.010585},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.023767},{"month":7,"riseRate":0.428571,"avgChangeRate":0.047576},{"month":8,"riseRate":0.5,"avgChangeRate":-0.032189},{"month":9,"riseRate":0.8,"avgChangeRate":0.065839},{"month":10,"riseRate":0.6,"avgChangeRate":0.092453},{"month":11,"riseRate":0.5,"avgChangeRate":0.05299},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011625}],"exchange":"SEHK","name":"晶泰控股","nameEN":"XTALPI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"晶泰控股,02228,晶泰控股股票,晶泰控股股票老虎,晶泰控股股票老虎国际,晶泰控股行情,晶泰控股股票行情,晶泰控股股价,晶泰控股股市,晶泰控股股票价格,晶泰控股股票交易,晶泰控股股票购买,晶泰控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}